Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Jayalakshmi Sridhar PhD
Translational Oncology
Xavier University
Shang Su, Phd
Cancer Biology
LSU School of Veterinary Medicine
Kevin Sullivan, MD
Cancer Biology
LSU Health - New Orleans
Gulshan Sunavala-Dossabhoy, PhD
Translational Oncology
LSU Health - New Orleans
Paul Sylvester PhD
Cancer Biology
University of Louisiana Monroe
Xiaochao Tan, PhD
Cancer Biology
Tulane University School of Medicine
Paul Thevenot, PhD
Translational Oncology
Ochsner Health
Raju Thomas MD
Translational Oncology
Tulane University School of Medicine
Aiguo Tian PhD
Cancer Biology
Tulane University School of Medicine